Literature DB >> 26078583

Laparoscopic fenestration of pancreatic serous cystadenoma: Minimally invasive approach for symptomatic benign disease.

Safi Dokmak1, Béatrice Aussilhou1, Fanjandrainy Rasoaherinomenjanahary1, Alain Sauvanet1, Marie-Pierre Vullierme1, Vinciane Rebours1, Philippe Lévy1.   

Abstract

Serous cystadenoma (SC) is a benign pancreatic cystic tumor. Surgical resection is recommended for symptomatic forms, but laparoscopic fenestration of large symptomatic macrocystic SC was not yet described in the literature. In this study, 3 female patients underwent laparoscopic fenestration for macrocystic SC (12-14 cm). Diagnosis was established via magnetic resonance imaging and endoscopic ultrasound, with intra-cystic dosage of tumors markers (ACE and CA19-9) in 2 patients. All patients were symptomatic and operated on 15-60 mo after diagnosis. Radiological evaluation showed constant cyst growth. Patients were informed about this new surgical modality that can avoid pancreatic resection. The mean operative time was 103 min (70-150 min) with one conversion. The post-operative course was marked by a grade A pancreatic fistula in one patient and was uneventful in the other two. The hospital stay was 3, 10, and 18 d, respectively. The diagnosis of macrocystic SC was histologically-confirmed in all cases. At the last follow-up (13-26 mo), all patients were symptom-free, and radiological evaluation showed complete disappearance of the cyst. Laparoscopic fenestration, as opposed to resection, should be considered for large symptomatic macrocystic SC, thereby avoiding pancreatic resection morbidity and mortality.

Entities:  

Keywords:  Laparoscopic fenestration; Pancreatic serous cystadenoma; Symptomatic

Mesh:

Substances:

Year:  2015        PMID: 26078583      PMCID: PMC4462747          DOI: 10.3748/wjg.v21.i22.7047

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

1.  851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital.

Authors:  Nakul P Valsangkar; Vicente Morales-Oyarvide; Sarah P Thayer; Cristina R Ferrone; Jennifer A Wargo; Andrew L Warshaw; Carlos Fernández-del Castillo
Journal:  Surgery       Date:  2012-07-06       Impact factor: 3.982

2.  Growth pattern of serous cystic neoplasms of the pancreas: observational study with long-term magnetic resonance surveillance and recommendations for treatment.

Authors:  Giuseppe Malleo; Claudio Bassi; Roberto Rossini; Riccardo Manfredi; Giovanni Butturini; Marta Massignani; Marina Paini; Paolo Pederzoli; Roberto Salvia
Journal:  Gut       Date:  2011-09-22       Impact factor: 23.059

3.  Macrocystic form of serous pancreatic cystadenoma.

Authors:  Denis Chatelain; Pascal Hammel; Dermot O'Toole; Benoît Terris; Valérie Vilgrain; Laurent Palazzo; Jacques Belghiti; Philippe Lévy; Philippe Ruszniewski; Jean-François Fléjou
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

4.  Rate of growth of pancreatic serous cystadenoma as an indication for resection.

Authors:  Kevin M El-Hayek; Nancy Brown; Colin O'Rourke; Gavin Falk; Gareth Morris-Stiff; R Matthew Walsh
Journal:  Surgery       Date:  2013-10       Impact factor: 3.982

5.  Multicenter study of serous cystic neoplasm of the Japan pancreas society.

Authors:  Wataru Kimura; Toshiyuki Moriya; Ichiro Hirai; Keiji Hanada; Hideki Abe; Akio Yanagisawa; Noriyoshi Fukushima; Nobuyuki Ohike; Michio Shimizu; Takashi Hatori; Naotaka Fujita; Hiroyuki Maguchi; Yasuhiro Shimizu; Kenji Yamao; Tamito Sasaki; Yoshiki Naito; Satoshi Tanno; Kosuke Tobita; Masao Tanaka
Journal:  Pancreas       Date:  2012-04       Impact factor: 3.327

6.  MRI features of serous oligocystic adenoma of the pancreas: differentiation from mucinous cystic neoplasm of the pancreas.

Authors:  J H Lee; J K Kim; T H Kim; M-S Park; J-S Yu; J-Y Choi; J H Kim; Y B Kim; K W Kim
Journal:  Br J Radiol       Date:  2011-02-08       Impact factor: 3.039

Review 7.  Risk of malignancy in serous cystic neoplasms of the pancreas.

Authors:  Oliver Strobel; Kaspar Z'graggen; Friedrich H Schmitz-Winnenthal; Helmut Friess; Andreas Kappeler; Arthur Zimmermann; Waldemar Uhl; Markus W Büchler
Journal:  Digestion       Date:  2003-08-29       Impact factor: 3.216

8.  Prevalence of unsuspected pancreatic cysts on MDCT.

Authors:  Thomas A Laffan; Karen M Horton; Alison P Klein; Bruce Berlanstein; Stanley S Siegelman; Satomi Kawamoto; Pamela T Johnson; Elliot K Fishman; Ralph H Hruban
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

9.  Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm.

Authors:  Peter J Allen; Li-Xuan Qin; Laura Tang; David Klimstra; Murray F Brennan; Anna Lokshin
Journal:  Ann Surg       Date:  2009-11       Impact factor: 12.969

10.  Serous cyst adenoma of the pancreas: appraisal of active surgical strategy before it causes problems.

Authors:  Ho Kyoung Hwang; Hyunki Kim; Chang Moo Kang; Woo Jung Lee
Journal:  Surg Endosc       Date:  2011-12-17       Impact factor: 4.584

View more
  2 in total

Review 1.  [Minimally invasive and robot-assisted surgery for pancreatic cystic tumors].

Authors:  T Welsch; M Distler; J Weitz
Journal:  Chirurg       Date:  2017-11       Impact factor: 0.955

2.  Giant Serous Cystadenoma of the Pancreas (⩾10 cm): The Clinical Features and CT Findings.

Authors:  Qing-Yu Liu; Jun Zhou; Yu-Rong Zeng; Xiao-Feng Lin; Jun Min
Journal:  Gastroenterol Res Pract       Date:  2016-08-16       Impact factor: 2.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.